Your Cholesterol Ratios Are Off. Your Genes May Be Why.

Your LDLR gene produces the LDL receptor, a protein that sits on the surface of your cells and grabs LDL cholesterol particles from your bloodstream. Think of it as a cellular vacuum cleaner for bad cholesterol. Your cells need these receptors to pull LDL in; without them, LDL stays in your blood and accumulates.

If you carry a pathogenic variant in LDLR, those receptors don’t work properly, and your cells can’t grab LDL efficiently. There are over 1,000 known pathogenic variants. Familial hypercholesterolemia, which affects roughly 1 in 300 people, is caused by LDLR mutations. People with LDLR variants often have LDL levels two to ten times higher than normal, and diet alone cannot bring them down.

You’ve probably felt this as frustration: you cut fat, you exercise, your bloodwork still shows sky-high LDL. Your ratio doesn’t improve because your cells literally cannot pull the cholesterol out of your blood fast enough. It’s not laziness or poor discipline. Your cellular machinery is broken.

APOE is one of the most important genes for cholesterol metabolism. It comes in three versions: e2, e3, and e4. You carry two copies (one from each parent), and which combination you have fundamentally changes how your body handles cholesterol.

If you carry the e4 variant, your body naturally keeps LDL higher and clears it more slowly. Roughly 25% of people of European ancestry carry at least one e4 copy. APOE4 carriers have higher baseline LDL, worse cholesterol ratios, and respond less dramatically to diet changes than e3 and e2 carriers. This isn’t a character flaw; it’s your genetic set point.

Your ratio may look broken because you’re being compared to an average that doesn’t match your genetics. If you’re an e4 carrier, your LDL naturally runs higher, and your HDL naturally runs lower. No amount of Mediterranean diet or statins will push you into the e2 or e3 normal range if you have two e4 copies. You’re fighting your own biology.

PCSK9 is a protein that destroys LDL receptors. When it’s overactive, it breaks down the very receptors your cells need to grab cholesterol from your blood. Think of it as your body destroying its own cleanup crew.

Gain-of-function variants in PCSK9, which are carried by roughly 1-3% of the population, make PCSK9 hyperactive. These variants markedly elevate LDL levels because your cells have fewer working receptors to pull cholesterol out of your bloodstream. You could have perfectly functioning LDLR genes, but if your PCSK9 is overactive, it doesn’t matter because the receptors get destroyed faster than they can work.

Your ratio isn’t improving because your cells are losing their cholesterol-clearing machinery as fast as it’s made. You cut fat; your liver makes more PCSK9 to destroy even more receptors. It’s a losing battle with standard diet alone.

APOB is the protein that sits on the surface of every LDL particle and acts as the handle that lets the LDL receptor grab it. If APOB is defective, the LDL receptor can’t bind the cholesterol particle, even if the receptor is working perfectly.

Certain variants in APOB, like R3527Q, prevent proper binding. These variants cause familial hypercholesterolemia in roughly 5% of FH cases. People with APOB variants have LDL particles that literally cannot attach to cells, so cholesterol accumulates in the bloodstream regardless of receptor abundance.

You might have excellent LDLR receptors and normal PCSK9, but if your APOB is defective, your LDL particles are invisible to your cells. Your ratio stays broken because the cholesterol particles have a broken communication code; they can’t signal that they need to be pulled in.

CETP is a protein that transfers cholesterol from protective HDL to LDL and VLDL particles. When CETP is overactive, it depletes your HDL and makes your LDL particles larger and more harmful. When CETP is underactive, your HDL stays high and LDL particles stay smaller and less atherogenic.

CETP variants like TaqIB and I405V are carried by roughly 40% of the population. Variants that reduce CETP activity can raise HDL and improve ratios, but they also alter LDL particle composition in ways that sometimes increase cardiovascular risk. The relationship between CETP variants and cholesterol ratios is complex and directional.

Your HDL might be low not because you’re not exercising enough, but because your CETP is overactive and is transferring your protective cholesterol into dangerous LDL particles. Or your HDL might be high but it’s not providing protection because your LDL particles are packed with cholesterol from CETP transfer.

Lipoprotein(a), or Lp(a), is a cholesterol particle that your liver produces based almost entirely on your genes. It’s independent of diet, exercise, and most medications. It acts like LDL but is more inflammatory and more likely to cause clots in your arteries.

Roughly 20% of the population has elevated Lp(a) due to genetic variants. Elevated Lp(a) is a strong independent cardiovascular risk factor, and it’s largely genetically determined, not lifestyle determined. You can have perfect LDL, excellent HDL, and still have dangerously high Lp(a) because of your genes.

Your cholesterol ratio might look better on paper while your actual cardiovascular risk is climbing because nobody is measuring Lp(a). Standard lipid panels ignore it. Your genes might be producing a dangerous particle that nobody is even looking for.